- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Healthcare-Associated Pneumonia in South Africa
Total 455 results
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
PfizerTerminatedCOVID-19United States, Malaysia, Thailand, Turkey, Spain, Czechia, Poland, Bulgaria, Japan, Korea, Republic of, South Africa, Hungary, Argentina, Brazil, Colombia, Mexico, Puerto Rico, Romania, Slovakia, Ukraine
-
PfizerCompletedCOVID-19United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
-
PfizerCompletedPneumonia, Pneumococcal | Gram-positive Bacterial Infections | Community Acquired InfectionsUnited States, Slovakia, Spain, Taiwan
-
VA Office of Research and DevelopmentTerminated
-
BayerCompletedPneumoniaBelgium, Germany, Spain, Greece, France, Netherlands, Chile, Mexico, Poland, South Africa, United Kingdom, Argentina, Colombia, Israel, Lithuania, Peru, Portugal, Sweden
-
National Institute of Allergy and Infectious Diseases...Completed
-
GlaxoSmithKlineCompletedCOVID-19 | SARS-CoV-2Australia, United States, Philippines
-
Gilead SciencesCompletedCOVID-19United States, Japan
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaboratorsCompletedCovid19 | CoronavirusUnited States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
-
Abbott NutritionTerminatedPneumoniaUnited States, Puerto Rico
-
OctapharmaCompletedCovid-19United States, Russian Federation, Ukraine
-
AbbVieCompletedCoronaVirus Disease-2019 (COVID-19)United States, Hungary, Israel, Netherlands, Puerto Rico
-
Australian and New Zealand Intensive Care Research...The AlfredNot yet recruitingPneumonia | Extracorporeal Membrane Oxygenation | Mechanical Ventilation Complication | Hypoxemia | COVID-19 Respiratory Infection | Acute Respiratory Distress Syndrome Due to COVID-19Australia, Germany
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
Eisai Inc.CompletedThrombocytopenia Associated With Liver DiseaseUnited States, China, Spain, Argentina, Belgium, Israel, Mexico, Romania, Japan, Brazil, Russian Federation, Germany, Italy, Czechia, Canada, Australia, France
-
PharmaMarTerminatedCOVID-19Spain, Portugal, France, Belgium, Italy, Greece, Hungary, Georgia, Israel, Poland, United Kingdom
-
ASH Research CollaborativeUniversity of Pennsylvania; American Society of HematologyActive, not recruiting
-
Regeneron PharmaceuticalsTerminated
-
GlaxoSmithKlineRecruitingRespiratory Syncytial Virus InfectionsUnited States, Belgium, Netherlands, Spain
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsRecruitingCovid19 | COVID | SARS-CoV2 InfectionUnited States, Spain, Argentina, Denmark, Greece, India, Mexico, Uganda
-
Daiichi Sankyo, Inc.Syneos HealthCompletedPain Associated With FibromyalgiaUnited States, France, Germany, Serbia, Netherlands, Denmark, Sweden, Canada, Norway, Finland, Czechia
-
TakedaCompletedPneumoniaDenmark, Hungary, Australia, Austria, Belgium, Estonia, Finland, Germany, Greece, Israel, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Switzerland, United Kingdom
-
PfizerCompleted
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, Belgium, France, Spain, United Kingdom
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruitingCOVID-19United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedSystemic Sclerosis-associated Interstitial Lung DiseaseUnited States, Canada, Italy, Poland, Spain, Argentina, Australia, Israel, United Kingdom
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
Gilead SciencesTerminatedCOVID-19United States, Spain, Denmark, United Kingdom
-
BioNTech SEPfizerActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Pfizer; University of Copenhagen and other collaboratorsTerminatedCOVID-19United States, Denmark
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
Viracta Therapeutics, Inc.RecruitingEBV Related Non-Hodgkin's Lymphoma | Epstein-Barr Virus Associated Lymphoproliferative Disorder | EBV-Related PTLD | EBV Associated Lymphoma | EBV-Positive DLBCL, NOS | EBV Related PTCL, NOSUnited States, Spain, Italy, United Kingdom, Singapore, Taiwan, Korea, Republic of, Germany, Canada, Brazil, Australia, France, Malaysia, Hong Kong, Israel
-
Merck Sharp & Dohme LLCTerminatedCoronavirus Disease (COVID-19)Colombia, United States, Brazil, Canada, Chile, France, Israel, Italy, Korea, Republic of, Mexico, Philippines, Poland, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Nodal Marginal Zone LymphomaUnited States
-
Novartis PharmaceuticalsCompletedPneumoniaUnited States, France, United Kingdom, Spain, Belgium, Canada, Korea, Republic of, Argentina, Australia, Brazil, Chile, Germany, Malaysia, Netherlands, New Zealand, Peru, Singapore, South Africa
-
Blade TherapeuticsClinipace WorldwideCompletedCovid19 | Sars-CoV-2United States, Brazil
-
Revive Therapeutics, Ltd.Terminated
-
AstraZenecaIqvia Pty LtdCompletedPhase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOVID-19 | SARS-CoV-2United States, Chile, Peru
-
Regeneron PharmaceuticalsTerminatedCOVID-19United States, Mexico, Romania
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, United Kingdom
-
NovavaxActive, not recruiting
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
PfizerTerminatedPneumonia | Sepsis | Bacteremia | MeningitisColombia, Brazil, Costa Rica
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Korea, Republic of
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences; University... and other collaboratorsCompleted
-
Daiichi Sankyo, Inc.Syneos HealthCompletedPain Associated With FibromyalgiaUnited States, Poland, Spain, Argentina, Austria, Belarus, Belgium, Chile, Colombia, Israel, Mexico, Portugal, Slovenia, Switzerland
-
PfizerCompleted